Clik here to view.
Mylan cuts EpiPen price in half after criticism
By Sarah Faulkner Mylan (NSDQ:MYL) said today that it would reduce the out-of-pocket patient cost for its EpiPen product, after being widely criticized for raising the price nearly 500% since 2009....
View ArticleClik here to view.
EarlyBird Venture Capital launches $135m medtech fund
Earlybird Venture Capital today announced the 1st closing of its Earlybird Health Tech Fund, which has a target size of between $112 million and $135 million (EU €110-120 million). Investors in the...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for August 25, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
FDA warns on programmable syringe pumps
The FDA today released a safety communication warning of problems with lack of flow continuity when programmable syringe pumps are set to low flow rates. The federal watchdog released the safety notice...
View ArticleClik here to view.
Report: Coloplast looks to expand in Minnesota
Coloplast (CPH:COLO B) is looking to expand its worker base in Minnesota, according to a new report from the Twin Cities Business Mag. The company, which acquired the urology business mentor Minnesota...
View ArticleClik here to view.
Study: Drug-coated balloons beat plain balloon angioplasty in peripheral...
Drug-coated balloon treatments reduce the risk of target lesion revascularization in treating femoropopliteal artery disease by 67% when compared to plain balloon angioplasty procedures, according to a...
View ArticleClik here to view.
Amedica wins expanded FDA indication for Valeo II spinal fusion devices
Amedica (NSDQ:AMDA) said yesterday it won expanded FDA clearance for additional sizes of its Valeo II lateral lumbar interbody fusion device. The Valeo II lateral lumbar fusion device is made out of...
View ArticleClik here to view.
Using umbilical cords to fix hearts
Cardiac surgery is reducing the use of plastic — starting with an operation for newborns who have life-threatening heart disease generally called single ventricle. Single ventricle is so dangerous...
View ArticleClik here to view.
Titan Medical again extends negotiations with Chinese distributor
Titan Medical (TSX:TMD) said this week that it’s again extending negotiations with a Chinese private equity shop, after a prior, 3-month add-on expired August 19. The Toronto-based robot-assisted...
View ArticleClik here to view.
Medtronic to cover HeartWare’s cash burn by cutting back on other heart...
Medtronic (NYSE:MDT), which earlier this week closed on the $1.1 billion buyout of implantable cardiac pump maker HeartWare, plans to cover HeartWare’s cash burn by cutting other heart failure R&D...
View ArticleClik here to view.
Patient perspective: Why I’m not that worried about my St. Jude Medical...
By Dave Price No one can say we weren’t warned. Among the more random and capricious threats of modern life – terrorist attacks, Boston-area roadways, a Trump presidency – my still-new pacemaker...
View ArticleClik here to view.
Scion Medical’s Medlink closes $4m Perseon buyout
Perseon Medical (NSDQ:PRSN) said yesterday that it closed the sale of its assets this week and reverted to its former name, BSD Medical, as part of the deal. The $4.35 million sale, which closed August...
View ArticleClik here to view.
GE Healthcare, Mission Health ink 10-year outcomes-based development deal
GE Healthcare (NYSE:GE) said today that it inked a 10-year, outcomes-based development deal with Mission Health to streamline care and improve cost efficiency at Mission Health’s facilities. Through...
View ArticleClik here to view.
U.K. regulator MHRA updates guidelines on medical app requirements
The U.K. regulatory body MHRA recently updated its guidelines for what health and medical applications should be subject to medical device oversight. The updated guidelines cover applications that...
View ArticleClik here to view.
Transforming iPad safety in healthcare: A case in point
The FlipPad, an antimicrobial case that allows the iPad to be cleaned by the harshest chemicals and the first case to feature a Corning Antimicrobial glass screen sensitive enough to be used with...
View ArticleClik here to view.
MIT, Singapore Univ. dev 3-D-printed structures that “remember” their shapes
By Sarah Faulkner Engineers from MIT and Singapore University of Technology and Design are using light to create 3D structures that remember their shape when triggered by external stimuli like...
View ArticleClik here to view.
Alere files suit against Abbott to force $6B buyout
Alere (NYSE:ALR) said today it filed a lawsuit against Abbott (NYSE:ABT), looking to force the company to obtain all antitrust approvals required to complete its $5.8 billion acquisition of Alere. The...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for August 26, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Getinge, GE Healthcare launch ‘hybrid OR’ flexible angiography combo
Getinge (PINK:GETI B) said yesterday it launched a new combined angiography system designed for hybrid operating rooms as a collaborative project with GE Healthcare (NYSE:GE). The system combines...
View ArticleClik here to view.
Ex-Abbott exec Simhambhatla is new Alphaeon CEO | Personnel Moves August 26,...
Ex-Abbott exec Simhambhatla is new Alphaeon CEO Healthcare and social commerce company Alphaeon said last week it tapped former Abbott (NYSE:ABT) senior veep Dr. Murthy Simhambhatla as its new CEO and...
View Article